Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Pionyr on the sale. Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Area 1 Security in the transaction. Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, has...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Yigal Arnon & Co. advised Intel, while Latham & Watkins, LLP and FISCHER (FBC & Co.) advised Tower...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Plaid in the transaction. Plaid executed the acquisition of Cognito, an identity verification and compliance (KYC, AML) platform that makes it faster, easier,...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell LLP and Bennett Jones LLP represented Canadian Pacific Railway, while Wachtell, Lipton, Rosen & Katz, Davies represented Kansas City Southern in the transaction....
You must be a Standard 1 Year member to access this content.
